Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Advancements and Disparities in Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Multiple Myeloma: Insights from China

    Abstract: This retrospective study aimed to delineate the utilization trends of autologous hematopoietic stem cell transplantation (AHSCT) for lymphoma and multiple myeloma (MM) in China, utilizing data from 211 AHSCT…

    2024.03.18
  • The Prognostic Power of Tumor-Infiltrating B Cells in Diffuse Large B-cell Lymphoma: Implications for Precision Medicine

    Introduction: Diffuse large B-cell lymphoma (DLBCL) represents a complex entity characterized by diverse clinical outcomes and treatment responses. Amidst this complexity, the tumor microenvironment has emerged as a key determinant…

    2024.03.18
  • Anlotinib: A Promising Therapeutic Approach for Transformed Follicular Lymphoma

    Study Design: The research employed a comprehensive approach, encompassing both in vitro and in vivo evaluations. In vitro assessments involved exposing tFL cells to varying concentrations of anlotinib, measuring cell…

    2024.03.18
  • The Role of SHP-1 and SHP-2 in CD8+ T Cell Regulation during Lymphocytic Choriomeningitis Virus Infection: Insights into Stage-Specific Functional Interplay

    Introduction: The modulation of CD8+ T cell responses in immunological contexts, particularly in the realm of viral infections and tumor immunology, demands a deeper understanding of the underlying molecular pathways.…

    2024.03.18
  • Assessing the Impact of Omicron Variant on Allo-HSCT Recipients in China: Insights from a Single-Center Observational Study

    Study Design: This observational cohort study, conducted at the First Affiliated Hospital of Soochow University, aimed to assess the impact of the Omicron variant of SARS-CoV-2 on allo-hematopoietic stem cell…

    2024.03.17
  • The Complex Impact of CMV Reactivation Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comprehensive Review

    Introduction: Allogeneic hematopoietic stem cell transplantation stands as a cornerstone treatment for hematologic malignancies, yet the specter of CMV reactivation looms large, threatening the well-being of transplant recipients. CMV reactivation,…

    2024.03.17
  • Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Option for Diffuse Large B-Cell Lymphoma Patients After CAR-T Therapy Failure

    Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment landscape for refractory/relapsed diffuse large B-cell lymphoma (R/R DLBCL). However, despite its remarkable efficacy, a subset of patients experiences…

    2024.03.17
  • Exploring CD22 as an Alternative Target in B-cell Hematologic Malignancies: A Comprehensive Review of Study Design, Clinical Implications, and Future Perspectives

    Introduction: The introduction of chimeric antigen receptor (CAR)-T cell therapy targeting CD19 has undeniably transformed the treatment landscape for patients with relapsed or refractory (R/R) B-cell malignancies. However, a persistent…

    2024.03.17
«previous next»
Recent Posts
  • Professor Yanhong Deng: Precision and Accessibility Go Hand in Hand—China-Developed Panitumumab N01 Opens a New Era of Fully Human Anti-EGFR Antibodies in mCRC
  • CSCO 2026 Global Perspectives | Professor William Gradishar: From Dual HER2 Blockade to the ADC Era—The Future and Transformation of HER2-Positive Breast Cancer Treatment
  • CSCO 2026 | Professor Binghao Li: Vebreltinib Plus Immunotherapy Explores a New Treatment Strategy for Advanced Clear Cell Sarcoma, with Potential Association Between c-MET Expression and Clinical Benefit
  • CSCO Global Perspectives | Professor Yi-Long Wu in Conversation with Professor Everett Vokes: Advances in MET-Amplified NSCLC—From Resistance Mechanism to Actionable Oncogenic Driver
  • CSCO 2026 | Celebrating Excellence in Oncology: Five Major Award Categories Announced at the CSCO Plenary Session
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top